Sophie Broutin

AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations

Katharine Yen, Jeremy Travins, Fang Wang et al. · Cancer Discovery · 2017 · 444 citations · Full text

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Peng Liu, Liwei Zhao, Jonathan Pol et al. · Nature Communications · 2019 · 283 citations · Full text

Somatic<i>RAS</i>Mutations Occur in a Large Proportion of Sporadic<i>RET</i>-Negative Medullary Thyroid Carcinomas and Extend to a Previously Unidentified Exon

Amélie Boichard, L. Croux, Abir Al Ghuzlan et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 149 citations · Full text

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development

François Lemonnier, Rob A. Cairns, Satoshi Inoue et al. · Proceedings of the National Academy of Sciences · 2016 · 114 citations · Full text

Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled Study

Marie-Hélène Massicotte, Isabelle Borget, Sophie Broutin et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 99 citations · Full text